AU to continue purchasing Oxford-AstraZeneca vaccines

The African Union says it will go ahead with the purchase of Oxford-AstraZeneca vaccines as planned this year.  This is despite South Africa stopping its rollout of the jab because initial trial data suggested it offers minimal protection against mild and moderate disease from the virus variant discovered in that country.  CGTN’s Coletta Wanjohi reports from Addis Ababa Subscribe to us on YouTube: Follow us on: Facebook: Twitter: Instagram: